SCHEMBL5926314

SCHEMBL5926314

COC(=O)CC(NC(=O)c1cc(-c2ccc(OC)cc2)ccc1O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ TACR3 P29371 1/20 0.53
▸ DCAF1 Q9Y4B6 1/20 0.52
▸ ALDH1A1 P00352 3/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ NPC1 O15118 1/20 0.47
▸ PDE2A O00408 1/20 0.47
▸ UTS2R Q9UKP6 7/20 0.47
▸ MGLL Q99685 2/20 0.46
▸ THRB P10828 2/20 0.46
▸ HPGD P15428 2/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5927597 0.90 MMP12 (0.50) MEN1KMT2ATACR3DCAF1ALDH1A1
SCHEMBL5926559 0.90 TACR3 (0.51) TACR3DCAF1ALDH1A1NPC1HPGD
SCHEMBL5926460 0.89 TACR3 (0.53) MEN1KMT2ATACR3DCAF1ALDH1A1
SCHEMBL5927335 0.88 TACR3 (0.51) MEN1KMT2ATACR3DCAF1ALDH1A1
SCHEMBL5927088 0.88 TACR3 (0.51) MEN1KMT2ATACR3DCAF1ALDH1A1
SCHEMBL5926526 0.88 TACR3 (0.51) TACR3DCAF1UTS2R
SCHEMBL5927319 0.88 TACR3 (0.51) MEN1KMT2ATACR3DCAF1ALDH1A1
SCHEMBL5926760 0.88 TACR3 (0.51) MEN1KMT2ATACR3DCAF1ALDH1A1
SCHEMBL5927139 0.87 UTS2R (0.45) MEN1KMT2ATACR3DCAF1ALDH1A1
SCHEMBL5926414 0.87 TACR3 (0.50) MEN1KMT2ATACR3ALDH1A1PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276518-A1 Aryl and heteroaryl compounds and methods to modulate coagulation TRANSTECH PHARMA, INC. 2006-12-07 — — US disclosed
US-7122580-B2 Aryl and heteroaryl compounds and methods to modulate coagulation TRANSTECH PHARMA, INC. (US) 2006-10-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276518-A1 Aryl and heteroaryl compounds and methods to modulate coagulation TFPI, F9, F2 MEN1 3448/4885KMT2A 2112/4885TACR3 3996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback